January 23, 2026 by Mohr Marketing
The “Signed Case” is Dead: Why Smart Firms Are Switching to AI-Powered Marketing Support Legal Marketing / Ethics & Compliance For years, the “Holy Grail” of personal injury marketing was the “Signed Case”βa neat little package where a vendor did everything, including signing the retainer, and handed it to the attorney. But in 2026, that…
Continue reading Why Smart Firms Are Switching to AI-Powered Marketing Support
January 22, 2026 by Mohr Marketing
Allocation Strategy: Bard (MDL 2846) vs. Covidien (MDL 3029) EXECUTIVE SUMMARY The “Hernia Mesh” bucket is no longer a single asset class. As we enter Q1 2026, the litigation has bifurcated into two distinct phases. Bard has transitioned into a mature “Administration & Cleanup” phase, where value is found only in specific, high-damage claims. Covidien,…
Continue reading MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
January 22, 2026 by Mohr Marketing
The end of the “Lead Broker” model in MDLs With MDL judges increasingly scrutinizing plaintiff inventories and defense counsel flagging “bot” submissions in high-profile torts, the integrity of legal lead generation is facing a crisis. I am writing to share how Mohr Marketing is addressing this head-on. We have moved away from the traditional “Lead…
Continue reading Solving the “Fake Lead” Crisis in Mass Torts with AI
January 21, 2026 by Mohr Marketing
Bard Settlement vs. Covidien Growth: Where to Put Your Budget in 2026 For the last five years, MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc.) has been a cornerstone of many mass tort inventories. However, following Becton Dickinsonβs October 2024 announcement of a global settlement framework (approx. $1.9 billion reserved for ~38,000 claims), the strategy…
Continue reading The Bard Hernia Mesh Landscape in 2026
January 21, 2026 by Mohr Marketing
Mohr Marketing Launches “Post-Settlement” Protocol for Bard Mesh; Opens New Acquisition Channels for Emerging Covidien Litigation Dual-strategy for 2026: Strict “Tier 1” filtration for mature Bard dockets and aggressive growth focus for Covidien (MDL 3029). Mohr Marketing, a specialized digital agency for the legal sector, today announced a strategic overhaul of its hernia mesh acquisition…
Continue reading The “Hernia Mesh” bucket is no longer a single asset class
January 21, 2026 by Mohr Marketing
Mohr Marketing Launches “Post-Settlement” Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its “Tier 1” Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL…
Continue reading Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
January 20, 2026 by Mohr Marketing
Protecting Your Firm from Barratry, Capping, and Ethical Violations in the AI Era Disclaimer: This checklist is for informational purposes only and does not constitute legal advice. Attorneys should always consult their specific State Bar rules regarding advertising and solicitation. Part 1: The “Source & Origin” Test How is the lead generated? This is the…
Continue reading The 2026 MVA Lead Generation Compliance Checklist
January 19, 2026 by Mohr Marketing
Why “Brokered” Mass Tort cases are becoming a liability. Switch to Direct AI Acquisition. In the high-stakes world of Mass Torts, “Data Integrity” is the new gold. If you are building your docket by purchasing “signed cases” from third-party aggregators, you are facing three major risks: Dual Representation: The claimant has already been sold to…
Continue reading β οΈ Your “Inventory” might be at risk (Read this)
January 17, 2026 by Mohr Marketing
The “Broker Chain” Apocalypse: Why Mass Tort Firms Must Own Their Lead Generation in 2026 Category: Mass Tort Marketing / Legal Ethics If you are a Mass Tort attorney, you know the nightmare: You buy a docket of 500 cases from a vendor, only to find that 30% are “dual rep” (already signed by another…
Continue reading Why Mass Tort Firms Must Own Their Lead Generation
January 16, 2026 by Mohr Marketing
Are you tired of handing your law firmβs marketing budget over to a “Black Box”? For too long, attorneys have been trapped in a cycle of uncertainty, buying leads from vendors without knowing where they originated, what the ads looked like, or who else purchased the same data. At Mohr Marketing, we are shattering that…
Continue reading Stop Buying “Black Box” Leads. Itβs Time for a Glass Pipeline.